How sertraline alleviates depressive syndrome by modulating the intrinsic connectivity networks (ICNs) remains elusive. Herein, we take a network-based investigation on SN to rationalize the functional and behavior effect of the sertraline treatment using resting-state functional connectivity (rsFC). Our study demonstrated that the sertraline treatment exhibited beneficial modulations on the DNMTL–SN–thalamus pathway for alleviating depressive syndromes in MDD patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords